INMODE LTD (INMD)
IL0011595993 - Common Stock
INMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. INMD has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. INMD is cheap, but on the other hand it scores bad on growth. This makes INMD very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year INMD was profitable.
In the past year INMD had a positive cash flow from operations.
INMD had positive earnings in each of the past 5 years.
In the past 5 years INMD always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 18.65%, INMD belongs to the best of the industry, outperforming 97.33% of the companies in the same industry.
INMD has a Return On Equity of 20.85%. This is amongst the best in the industry. INMD outperforms 95.19% of its industry peers.
INMD has a better Return On Invested Capital (15.55%) than 96.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 8.23%.
The last Return On Invested Capital (15.55%) for INMD is well below the 3 year average (28.25%), which needs to be investigated, but indicates that INMD had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.65% | ||
| ROE | 20.85% | ||
| ROIC | 15.56% |
ROA(3y)27.49%
ROA(5y)27.16%
ROE(3y)31.31%
ROE(5y)31.63%
ROIC(3y)28.25%
ROIC(5y)27.22%
1.3 Margins
Looking at the Profit Margin, with a value of 36.26%, INMD belongs to the top of the industry, outperforming 98.40% of the companies in the same industry.
In the last couple of years the Profit Margin of INMD has grown nicely.
The Operating Margin of INMD (32.07%) is better than 98.93% of its industry peers.
In the last couple of years the Operating Margin of INMD has grown nicely.
INMD has a better Gross Margin (81.64%) than 94.12% of its industry peers.
INMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 32.07% | ||
| PM (TTM) | 36.26% | ||
| GM | 81.64% |
OM growth 3Y4.03%
OM growth 5Y4.81%
PM growth 3Y3.39%
PM growth 5Y12.47%
GM growth 3Y-0.57%
GM growth 5Y-0.32%
2. Health
2.1 Basic Checks
INMD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for INMD has been increased compared to 1 year ago.
Compared to 5 years ago, INMD has more shares outstanding
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.63
WACC9.57%
2.3 Liquidity
INMD has a Current Ratio of 10.68. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.68, INMD belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
A Quick Ratio of 9.91 indicates that INMD has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 9.91, INMD belongs to the best of the industry, outperforming 93.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 10.68 | ||
| Quick Ratio | 9.91 |
3. Growth
3.1 Past
The earnings per share for INMD have decreased strongly by -21.29% in the last year.
Measured over the past years, INMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.76% on average per year.
The Revenue for INMD has decreased by -15.06% in the past year. This is quite bad
INMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.48% yearly.
EPS 1Y (TTM)-21.29%
EPS 3Y34.38%
EPS 5Y45.76%
EPS Q2Q%14.75%
Revenue 1Y (TTM)-15.06%
Revenue growth 3Y33.65%
Revenue growth 5Y37.48%
Sales Q2Q%5.78%
3.2 Future
The Earnings Per Share is expected to decrease by -2.68% on average over the next years.
INMD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.69% yearly.
EPS Next Y-22.9%
EPS Next 2Y-8%
EPS Next 3Y-2.68%
EPS Next 5YN/A
Revenue Next Year-16.13%
Revenue Next 2Y-7%
Revenue Next 3Y-2.69%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.93 indicates a reasonable valuation of INMD.
Based on the Price/Earnings ratio, INMD is valued cheaper than 98.40% of the companies in the same industry.
INMD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.96.
With a Price/Forward Earnings ratio of 8.53, the valuation of INMD can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 99.47% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of INMD to the average of the S&P500 Index (23.82), we can say INMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.93 | ||
| Fwd PE | 8.53 |
4.2 Price Multiples
98.93% of the companies in the same industry are more expensive than INMD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 98.40% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.75 | ||
| EV/EBITDA | 3.25 |
4.3 Compensation for Growth
The excellent profitability rating of INMD may justify a higher PE ratio.
A cheap valuation may be justified as INMD's earnings are expected to decrease with -2.68% in the coming years.
PEG (NY)N/A
PEG (5Y)0.2
EPS Next 2Y-8%
EPS Next 3Y-2.68%
5. Dividend
5.1 Amount
No dividends for INMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INMODE LTD
NASDAQ:INMD (11/21/2024, 8:00:02 PM)
Premarket: 18.45 -0.04 (-0.19%)18.485
+0.25 (+1.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.41B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.93 | ||
| Fwd PE | 8.53 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.65% | ||
| ROE | 20.85% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 32.07% | ||
| PM (TTM) | 36.26% | ||
| GM | 81.64% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 10.68 | ||
| Quick Ratio | 9.91 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-21.29%
EPS 3Y34.38%
EPS 5Y
EPS Q2Q%
EPS Next Y-22.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.06%
Revenue growth 3Y33.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y